HSV 1 + 2/VZV

The Quidel® Molecular Direct HSV 1+2/VZV Assay is a multiplex real-time PCR assay for the qualitative detection and identification of viral nucleic acids extracted from lesion swabs. The assay is intended to aid in the differential diagnosis of Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) and Varicella-zoster virus (VZV) also known as Human Herpes-3. VZV is the virus that causes chicken pox.

Apply for a free evaluation kit

Benefits of Quidel® Molecular Direct HSV 1+2/VZV Kits

Benefits
CE-IVD
Genital herpes is misdiagnosed 20% of the time1
In the US, 16 percent of adults are HSV-2 seropositive, but only 10 percent to 25 percent of persons with HSV-2 infection have recognized genital herpes. Moreover, most HSV-2 infections are acquired from persons without a clinical history of genital herpes 1
Early identification can reduce transmission and suppress reactivation2
Plans can be made to avoid transmission to neonates

Product Information

Ordering Information

Product

Quantity

Cat. No.

Quidel® Molecular Direct HSV 1+2/VZV Assay
(For sale in Europe only. The assay is validated on the QuantStudio™ Dx and the 7500 Fast Dx Real-time Instruments in Europe)

96-reaction kit

4481147

Quidel Molecular HSV/VZV External Controls 10-reactions 4481484

References

  1. Hook, Edward W. III. 2012. “A New Look at Genital Herpes: The Critical Role of the Laboratory in Diagnosis and Management.” Medical Laboratory Observer. 2012 July 44(7):8-12.
  2. Emmert, David. 2000. “Treatment of Common Cutaneous Herpes Simplex Virus Infections”. American Family Physician. 2000.